Global Respiratory Syncytial Virus(RSV) Therapeutics Market Growth (Status and Outlook) 2022-2028

February 2022 | 86 pages | ID: G4C97A41F739EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

As the global economy mends, the 2021 growth of Respiratory Syncytial Virus(RSV) Therapeutics will have significant change from previous year. According to our (LP Information) latest study, the global Respiratory Syncytial Virus(RSV) Therapeutics market size is USD million in 2022 from USD 552.4 million in 2021, with a change of % between 2021 and 2022. The global Respiratory Syncytial Virus(RSV) Therapeutics market size will reach USD 827.3 million in 2028, growing at a CAGR of 5.9% over the analysis period.

The United States Respiratory Syncytial Virus(RSV) Therapeutics market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Respiratory Syncytial Virus(RSV) Therapeutics market, reaching US$ million by the year 2028. As for the Europe Respiratory Syncytial Virus(RSV) Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.

Global main Respiratory Syncytial Virus(RSV) Therapeutics players cover Roche, AstraZeneca, Merck, and AbbVie, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of Respiratory Syncytial Virus(RSV) Therapeutics market by product type, application, key players and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.

• Palivizumab
• Ribavirin
• Others

Segmentation by sale channel: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.

• Hospital Pharmacies
• Drug Stores
• Retail Pharmacies
• Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.

• Roche
• AstraZeneca
• Merck
• AbbVie
• Bausch Health
• GlaxoSmithKline
• ReViral
• Gilead Sciences
• Teva Pharmaceutical

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2017-2028
  2.1.2 Respiratory Syncytial Virus(RSV) Therapeutics Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Respiratory Syncytial Virus(RSV) Therapeutics Segment by Type
  2.2.1 Palivizumab
  2.2.2 Ribavirin
  2.2.3 Others
2.3 Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type
  2.3.1 Respiratory Syncytial Virus(RSV) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028)
  2.3.2 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Type (2017-2022)
2.4 Respiratory Syncytial Virus(RSV) Therapeutics Segment by Sale Channel
  2.4.1 Hospital Pharmacies
  2.4.2 Drug Stores
  2.4.3 Retail Pharmacies
  2.4.4 Others
2.5 Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel
  2.5.1 Respiratory Syncytial Virus(RSV) Therapeutics Market Size CAGR by Sale Channel (2017 VS 2022 VS 2028)
  2.5.2 Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Sale Channel (2017-2022)

3 RESPIRATORY SYNCYTIAL VIRUS(RSV) THERAPEUTICS MARKET SIZE BY PLAYER

3.1 Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Players
  3.1.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue by Players (2020-2022)
  3.1.2 Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue Market Share by Players (2020-2022)
3.2 Global Respiratory Syncytial Virus(RSV) Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RESPIRATORY SYNCYTIAL VIRUS(RSV) THERAPEUTICS BY REGIONS

4.1 Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Regions (2017-2022)
4.2 Americas Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth (2017-2022)
4.3 APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth (2017-2022)
4.4 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth (2017-2022)
4.5 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth (2017-2022)

5 AMERICAS

5.1 Americas Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2017-2022)
5.2 Americas Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2017-2022)
5.3 Americas Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Region (2017-2022)
6.2 APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2017-2022)
6.3 APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Respiratory Syncytial Virus(RSV) Therapeutics by Country (2017-2022)
7.2 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2017-2022)
7.3 Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics by Region (2017-2022)
8.2 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2017-2022)
8.3 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RESPIRATORY SYNCYTIAL VIRUS(RSV) THERAPEUTICS MARKET FORECAST

10.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Forecast by Regions (2023-2028)
  10.1.1 Global Respiratory Syncytial Virus(RSV) Therapeutics Forecast by Regions (2023-2028)
  10.1.2 Americas Respiratory Syncytial Virus(RSV) Therapeutics Forecast
  10.1.3 APAC Respiratory Syncytial Virus(RSV) Therapeutics Forecast
  10.1.4 Europe Respiratory Syncytial Virus(RSV) Therapeutics Forecast
  10.1.5 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Forecast
10.2 Americas Respiratory Syncytial Virus(RSV) Therapeutics Forecast by Country (2023-2028)
  10.2.1 United States Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.2.2 Canada Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.2.3 Mexico Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.2.4 Brazil Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
10.3 APAC Respiratory Syncytial Virus(RSV) Therapeutics Forecast by Region (2023-2028)
  10.3.1 China Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.3.2 Japan Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.3.3 Korea Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.3.4 Southeast Asia Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.3.5 India Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.3.6 Australia Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
10.4 Europe Respiratory Syncytial Virus(RSV) Therapeutics Forecast by Country (2023-2028)
  10.4.1 Germany Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.4.2 France Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.4.3 UK Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.4.4 Italy Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.4.5 Russia Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
10.5 Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Forecast by Region (2023-2028)
  10.5.1 Egypt Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.5.2 South Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.5.3 Israel Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.5.4 Turkey Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
  10.5.5 GCC Countries Respiratory Syncytial Virus(RSV) Therapeutics Market Forecast
10.6 Global Respiratory Syncytial Virus(RSV) Therapeutics Forecast by Type (2023-2028)
10.7 Global Respiratory Syncytial Virus(RSV) Therapeutics Forecast by Sale Channel (2023-2028)

11 KEY PLAYERS ANALYSIS

11.1 Roche
  11.1.1 Roche Company Information
  11.1.2 Roche Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
  11.1.3 Roche Respiratory Syncytial Virus(RSV) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.1.4 Roche Main Business Overview
  11.1.5 Roche Latest Developments
11.2 AstraZeneca
  11.2.1 AstraZeneca Company Information
  11.2.2 AstraZeneca Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
  11.2.3 AstraZeneca Respiratory Syncytial Virus(RSV) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.2.4 AstraZeneca Main Business Overview
  11.2.5 AstraZeneca Latest Developments
11.3 Merck
  11.3.1 Merck Company Information
  11.3.2 Merck Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
  11.3.3 Merck Respiratory Syncytial Virus(RSV) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.3.4 Merck Main Business Overview
  11.3.5 Merck Latest Developments
11.4 AbbVie
  11.4.1 AbbVie Company Information
  11.4.2 AbbVie Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
  11.4.3 AbbVie Respiratory Syncytial Virus(RSV) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.4.4 AbbVie Main Business Overview
  11.4.5 AbbVie Latest Developments
11.5 Bausch Health
  11.5.1 Bausch Health Company Information
  11.5.2 Bausch Health Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
  11.5.3 Bausch Health Respiratory Syncytial Virus(RSV) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.5.4 Bausch Health Main Business Overview
  11.5.5 Bausch Health Latest Developments
11.6 GlaxoSmithKline
  11.6.1 GlaxoSmithKline Company Information
  11.6.2 GlaxoSmithKline Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
  11.6.3 GlaxoSmithKline Respiratory Syncytial Virus(RSV) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.6.4 GlaxoSmithKline Main Business Overview
  11.6.5 GlaxoSmithKline Latest Developments
11.7 ReViral
  11.7.1 ReViral Company Information
  11.7.2 ReViral Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
  11.7.3 ReViral Respiratory Syncytial Virus(RSV) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.7.4 ReViral Main Business Overview
  11.7.5 ReViral Latest Developments
11.8 Gilead Sciences
  11.8.1 Gilead Sciences Company Information
  11.8.2 Gilead Sciences Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
  11.8.3 Gilead Sciences Respiratory Syncytial Virus(RSV) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.8.4 Gilead Sciences Main Business Overview
  11.8.5 Gilead Sciences Latest Developments
11.9 Teva Pharmaceutical
  11.9.1 Teva Pharmaceutical Company Information
  11.9.2 Teva Pharmaceutical Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
  11.9.3 Teva Pharmaceutical Respiratory Syncytial Virus(RSV) Therapeutics Revenue, Gross Margin and Market Share (2020-2022)
  11.9.4 Teva Pharmaceutical Main Business Overview
  11.9.5 Teva Pharmaceutical Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Respiratory Syncytial Virus(RSV) Therapeutics Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Palivizumab
Table 3. Major Players of Ribavirin
Table 4. Major Players of Others
Table 5. Respiratory Syncytial Virus(RSV) Therapeutics Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Type (2017-2022)
Table 8. Respiratory Syncytial Virus(RSV) Therapeutics Market Size CAGR by Sale Channel (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2017-2022) & ($ Millions)
Table 10. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Sale Channel (2017-2022)
Table 11. Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue Market Share by Player (2020-2022)
Table 13. Respiratory Syncytial Virus(RSV) Therapeutics Key Players Head office and Products Offered
Table 14. Respiratory Syncytial Virus(RSV) Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Regions (2017-2022)
Table 19. Americas Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Country (2017-2022)
Table 21. Americas Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Type (2017-2022)
Table 23. Americas Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2017-2022) & ($ Millions)
Table 24. Americas Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Sale Channel (2017-2022)
Table 25. APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Region (2017-2022)
Table 27. APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Type (2017-2022)
Table 29. APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2017-2022) & ($ Millions)
Table 30. APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Sale Channel (2017-2022)
Table 31. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Country (2017-2022)
Table 33. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Type (2017-2022)
Table 35. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2017-2022) & ($ Millions)
Table 36. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Sale Channel (2017-2022)
Table 37. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size by Sale Channel (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Sale Channel (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Respiratory Syncytial Virus(RSV) Therapeutics
Table 44. Key Market Challenges & Risks of Respiratory Syncytial Virus(RSV) Therapeutics
Table 45. Key Industry Trends of Respiratory Syncytial Virus(RSV) Therapeutics
Table 46. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Forecast by Sale Channel (2023-2028) & ($ Millions)
Table 51. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share Forecast by Sale Channel (2023-2028)
Table 52. Roche Details, Company Type, Respiratory Syncytial Virus(RSV) Therapeutics Area Served and Its Competitors
Table 53. Roche Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
Table 54. Roche Respiratory Syncytial Virus(RSV) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Roche Main Business
Table 56. Roche Latest Developments
Table 57. AstraZeneca Details, Company Type, Respiratory Syncytial Virus(RSV) Therapeutics Area Served and Its Competitors
Table 58. AstraZeneca Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
Table 59. AstraZeneca Main Business
Table 60. AstraZeneca Respiratory Syncytial Virus(RSV) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. AstraZeneca Latest Developments
Table 62. Merck Details, Company Type, Respiratory Syncytial Virus(RSV) Therapeutics Area Served and Its Competitors
Table 63. Merck Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
Table 64. Merck Main Business
Table 65. Merck Respiratory Syncytial Virus(RSV) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Merck Latest Developments
Table 67. AbbVie Details, Company Type, Respiratory Syncytial Virus(RSV) Therapeutics Area Served and Its Competitors
Table 68. AbbVie Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
Table 69. AbbVie Main Business
Table 70. AbbVie Respiratory Syncytial Virus(RSV) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. AbbVie Latest Developments
Table 72. Bausch Health Details, Company Type, Respiratory Syncytial Virus(RSV) Therapeutics Area Served and Its Competitors
Table 73. Bausch Health Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
Table 74. Bausch Health Main Business
Table 75. Bausch Health Respiratory Syncytial Virus(RSV) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Bausch Health Latest Developments
Table 77. GlaxoSmithKline Details, Company Type, Respiratory Syncytial Virus(RSV) Therapeutics Area Served and Its Competitors
Table 78. GlaxoSmithKline Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
Table 79. GlaxoSmithKline Main Business
Table 80. GlaxoSmithKline Respiratory Syncytial Virus(RSV) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. GlaxoSmithKline Latest Developments
Table 82. ReViral Details, Company Type, Respiratory Syncytial Virus(RSV) Therapeutics Area Served and Its Competitors
Table 83. ReViral Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
Table 84. ReViral Main Business
Table 85. ReViral Respiratory Syncytial Virus(RSV) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. ReViral Latest Developments
Table 87. Gilead Sciences Details, Company Type, Respiratory Syncytial Virus(RSV) Therapeutics Area Served and Its Competitors
Table 88. Gilead Sciences Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
Table 89. Gilead Sciences Main Business
Table 90. Gilead Sciences Respiratory Syncytial Virus(RSV) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Gilead Sciences Latest Developments
Table 92. Teva Pharmaceutical Details, Company Type, Respiratory Syncytial Virus(RSV) Therapeutics Area Served and Its Competitors
Table 93. Teva Pharmaceutical Respiratory Syncytial Virus(RSV) Therapeutics Product Offered
Table 94. Teva Pharmaceutical Main Business
Table 95. Teva Pharmaceutical Respiratory Syncytial Virus(RSV) Therapeutics Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. Teva Pharmaceutical Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Respiratory Syncytial Virus(RSV) Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Type in 2021
Figure 7. Respiratory Syncytial Virus(RSV) Therapeutics in Hospital Pharmacies
Figure 8. Global Respiratory Syncytial Virus(RSV) Therapeutics Market: Hospital Pharmacies (2017-2022) & ($ Millions)
Figure 9. Respiratory Syncytial Virus(RSV) Therapeutics in Drug Stores
Figure 10. Global Respiratory Syncytial Virus(RSV) Therapeutics Market: Drug Stores (2017-2022) & ($ Millions)
Figure 11. Respiratory Syncytial Virus(RSV) Therapeutics in Retail Pharmacies
Figure 12. Global Respiratory Syncytial Virus(RSV) Therapeutics Market: Retail Pharmacies (2017-2022) & ($ Millions)
Figure 13. Respiratory Syncytial Virus(RSV) Therapeutics in Others
Figure 14. Global Respiratory Syncytial Virus(RSV) Therapeutics Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Sale Channel in 2021
Figure 16. Global Respiratory Syncytial Virus(RSV) Therapeutics Revenue Market Share by Player in 2021
Figure 17. Global Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 19. APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 20. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2017-2022 ($ Millions)
Figure 22. Americas Respiratory Syncytial Virus(RSV) Therapeutics Value Market Share by Country in 2021
Figure 23. Americas Respiratory Syncytial Virus(RSV) Therapeutics Consumption Market Share by Type in 2021
Figure 24. Americas Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Sale Channel in 2021
Figure 25. United States Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Region in 2021
Figure 30. APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Sale Channel in 2021
Figure 31. China Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Country in 2021
Figure 38. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Type in 2021
Figure 39. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Sale Channel in 2021
Figure 40. Germany Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size Market Share by Sale Channel in 2021
Figure 48. Egypt Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Respiratory Syncytial Virus(RSV) Therapeutics Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 54. APAC Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 55. Europe Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 57. United States Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 58. Canada Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 61. China Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 62. Japan Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 63. Korea Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 65. India Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 66. Australia Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 67. Germany Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 68. France Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 69. UK Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 70. Italy Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 71. Russia Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 72. Spain Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 75. Israel Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Respiratory Syncytial Virus(RSV) Therapeutics Market Size 2023-2028 ($ Millions)